Dingding Gao

shanghai university of traditional chinese medicine

H指数:17

被引数:875

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, Synthesis, and Structure–Activity Relationship Studies of Novel 3CL^pro Inhibitors

新型3CL<sup>pro</sup>抑制剂的分子设计、合成及其构效关系研究

ChemMedChem

IF3.4

2026-09-080

PRE

Structure-Based Design and Optimization of Novel PHGDH Inhibitors for Overcoming Erlotinib-Resistant Lung Cancer

基于结构的PHGDH新型抑制剂的设计与优化：克服厄洛替尼耐药性肺癌

Journal of Medicinal Chemistry

IF6.8

2026-06-090

PRE

Discovery of Novel Potent Indazole-based FXR Agonists via Scaffold Hopping for MASH Treatment

通过骨架跃迁发现新型强效吲唑基FXR激动剂用于MASH治疗

European Journal of Medicinal Chemistry

IF5.9

2025-09-270

PRE

Mechanistic insights into the dual anti-COVID-19 and anti-inflammatory actions of Zhengqi tablets

对正清片双重抗COVID-19和抗炎作用机制的研究

Journal of Ethnopharmacology

IF5.4

2025-07-040

PRE

Total Synthesis of (−)-2-Oxokolavenol: A Natural Neoclerodane Diterpene with Farnesoid X Receptor Transcriptional Activity

(−)-2-氧可拉文醇的全合成：一种具有法尼酯X受体转录活性的天然新克罗达烷二萜

Advanced Synthesis & Catalysis

IF4

2025-06-090

PRE

Novel inhibitors of STAT3: an updated patent review (2022-present)

STAT3的新型抑制剂：2022年至今的专利综述

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2025-04-220

PRE

Synthesis and evaluation of novel ebselen derivatives as urease inhibitors for combating Helicobacter pylori infections

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-04-010

PRE

Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors

发现天然儿茶酚衍生物作为共价SARS-CoV-2 3CLpro抑制剂

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-04-011

PRE

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines

MOLECULES

IF4.6

2024-03-211

OAAI

Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19

发现具有2-磺酰基-1，3，4-恶二唑支架的高效共价SARS-CoV-2 3CLpro抑制剂，用于对抗新型冠状病毒肺炎

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-11-0111

PRE

A practical preparation of bicyclic boronates via metal-free heteroatom-directed alkenyl sp2-C?H borylation

COMMUNICATIONS CHEMISTRY

IF6.2

2023-08-232

OAAI

Copper(I)-catalyzed asymmetric 1,3-dipolar cycloaddition of 1,3-enynes and azomethine ylides

NATURE COMMUNICATIONS

IF15.7

2023-08-048

OAAI

Nature-inspired catalytic asymmetric rearrangement of cyclopropylcarbinyl cation

SCIENCE ADVANCES

IF12.5

2023-05-126

OAAI

Thiourea-Promoted Cascade Dihalogenation-Cyclization of Cyclohexadienone-Containing 1,6-Enynes

ADVANCED SYNTHESIS & CATALYSIS

IF4

2023-01-313

PRE

Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-01-037

PRE

Novel inhibitors of the STAT3 signaling pathway: an updated patent review (2014-present)

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2022-04-013

PRE

Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for COVID-19

9，10-二氢菲衍生物作为新型冠状病毒肺炎SARS-CoV-2 3CLpro抑制剂的发现

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-01-0129

OAAI

Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitors

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-10-2122

PRE

A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-05-0134

PREAI

Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors

基于苯并噻唑的衍生物作为有效信号转导和转录激活因子3 (STAT3) 信号通路抑制剂的合理药物设计

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-04-0119

PREAI

Dingding Gao

个人简介

教育背景

工作经历

荣誉奖项

研究方向